Cardiac Conduction System Disease
"Cardiac Conduction System Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases characterized by pathological irregularities in the HEART CONDUCTION SYSTEM. They may be associated with other heart diseases and syndromes (e.g., BRUGADA SYNDROME; NEUROMUSCULAR DISEASE, HEART BLOCKS), isolated or may result from injuries. You can have a conduction disorder without having an arrhythmia, but some arrhythmias arise from conduction disorders. OMIM: 601144.
| Descriptor ID |
D000075224
|
| MeSH Number(s) |
C14.280.123
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cardiac Conduction System Disease".
Below are MeSH descriptors whose meaning is more specific than "Cardiac Conduction System Disease".
This graph shows the total number of publications written about "Cardiac Conduction System Disease" by people in this website by year, and whether "Cardiac Conduction System Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiac Conduction System Disease" by people in Profiles.
-
Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments. Expert Opin Ther Targets. 2024 May; 28(5):385-400.
-
Clinical outcomes of conduction system pacing versus biventricular pacing for cardiac resynchronization therapy: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2023 08; 34(8):1718-1729.
-
Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome. Heart Rhythm. 2022 01; 19(1):81-87.
-
Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes. J Med Chem. 2021 05 13; 64(9):5384-5403.
-
Progressive and Reversible Conduction Disease With Checkpoint Inhibitors. Can J Cardiol. 2017 10; 33(10):1335.e13-1335.e15.
-
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. Eur Heart J. 2017 Jun 07; 38(22):1764-1774.
-
Electrocardiographic abnormalities in elite high school athletes: comparison to adolescent hypertrophic cardiomyopathy. Br J Sports Med. 2016 Jan; 50(2):105-10.
-
Suicide left ventricle due to conduction disturbance following transcatheter aortic valve replacement and reversal with restoration of sinus rhythm: is there life after death? J Invasive Cardiol. 2015 Jun; 27(6):E107-9.
-
Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Diabetes Care. 2014 May; 37(5):1454-61.
-
[Auriculoventricular dissociation due to interference of sinus rhythm with ventricular rhythm (parasystole with tachycardiac ventricular rhythm)]. Med Interna (Bucur). 1958 May; 10(5):735-8.